Monographie - Ursodesoxycholique acid

Ursodesoxycholique acid

Keemiline struktuur

Viited : Ursodesoxycholique acid

	Tüüp	Avaldamine
2410	Ajaleht	Johnson CE, Streetman DD. Stability of oral suspensions of ursodiol made from tablets Am J Health-Syst Pharm 2002 ; 59: 361-363.
2449	Ajaleht	Johnson CE, Nesbitt J. Stability of ursodiol in an extemporaneously compounded oral liquid Am J Health-Syst Pharm 1995 ; 52: 1798-1800.
3782	Ajaleht	A. Santove?a, E. S?nchez-Negr?n, L. Charola, M. Llabr?s, J.B. Fari?a Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration Int J Pharm 2014 , 477, 1-2 : 32-38.
4177	Ajaleht	Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4. Int J Pharm Compound 2018 ;22,6:516-526
4214	Ajaleht	Pramar Y.V, Mandal T.K, Bostanian L.A, Nguyen A.TQ, Miller V, Morris T.C, Graves R.A. Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt. Int J Pharm Compound 2019 ;23,1:70-76
4498	Ajaleht	Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T. Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns. Pharmaceutical Technology in Hospital Pharmacy 2020